Table 3 Number of cancer deaths (annual rate per 1000 patients) by CKD status and cancer site
|  | CKD status (CKD EPI-estimated GFR (mL/min/1.73 m2)) | Dialysis (n = 3023) | All (n = 32057) | |||
|---|---|---|---|---|---|---|
Greater than 75 (n = 9594) | 60 to 75 (n = 6681) | 45 to 60 (n = 4931) | Less than 45 (n = 7828) | |||
Total person years | 49403 | 42615 | 36452 | 36538 | 12436 | 177443 |
All sites | 240 (5.8) | 272 (5.7) | 247 (5.9) | 246 (7.0) | 90 (10.8) | 1095 (6.2) |
Oral cavity and pharynx | 6 (0.2) | 2 (0.0) | 3 (0.1) | 4 (0.1) | 4 (0.2) | 19 (0.1) |
Digestive | 84 (2.0) | 94 (1.9) | 78 (1.9) | 81 (2.3) | 36 (4.2) | 373 (2.1) |
Respiratory | 71 (1.5) | 67 (1.5) | 44 (1.2) | 47 (1.4) | 20 (2.4) | 249 (1.4) |
Melanomas | 3 (0.1) | 3 (0.1) | 8 (0.2) | 6 (0.2) | 5 (0.7) | 25 (0.1) |
Breast | 5 (0.2) | 10 (0.2) | 6 (0.1) | 11 (0.2) | 0 (0.0) | 32 (0.2) |
Female genital | 5 (0.2) | 7 (0.1) | 13 (0.3) | 6 (0.2) | 2 (0.3) | 33 (0.2) |
Prostate | 9 (0.3) | 13 (0.3) | 22 (0.5) | 11 (0.3) | 1 (0.1) | 56 (0.3) |
Male genital | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Soft tissue/connective tissue | 1 (0.0) | 0 (0.0) | 6 (0.1) | 8 (0.3) | 1 (0.1) | 16 (0.1) |
Urinary tract | 10 (0.2) | 7 (0.1) | 7 (0.3) | 18 (0.5) | 5 (0.8) | 47 (0.3) |
Central nervous system | 9 (0.2) | 12 (0.2) | 10 (0.2) | 7 (0.2) | 2 (0.3) | 40 (0.2) |
Endocrine | 1 (0.0) | 1 (0.0) | 0 (0.0) | 1 (0.0) | 2 (0.3) | 5 (0.0) |
Haematological | 14 (0.3) | 29 (0.6) | 26 (0.5) | 20 (0.5) | 7 (0.8) | 96 (0.5) |
Multiple primary sites | 6 (0.2) | 13 (0.3) | 10 (0.2) | 6 (0.1) | 0 (0.0) | 35 (0.2) |
Unknown origin | 11 (0.2) | 12 (0.2) | 11 (0.3) | 16 (0.5) | 5 (0.7) | 55 (0.3) |
Bone and cartilage | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Others | 3 (0.0) | 0 (0.0) | 1 (0.1) | 0 (0.0) | 0 (0.0) | 4 (0.0) |
Site data not available | 2 | 2 | 2 | 4 | 0 | 10 |